Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Jane Kirby

Breakthrough for endometriosis sufferers as first-of-its-kind pill to be available on NHS

A first-of-its-kind pill for endometriosis has been approved for NHS use, offering hope for people in England suffering from the debilitating condition.

The combination drug, relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo), is the first long-term daily pill licensed to treat endometriosis.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.